Treatment of pan-drug resistant Acinetobacter baumannii

被引:30
作者
Lee, CM
Lim, HK
Liu, CP
Tseng, HK
机构
[1] Taipei Med Univ, Div Infect Dis, Dept Internal Med, Taipei, Taiwan
[2] Mackay Mem Hospl, Nursing & Management Coll, Taipei, Taiwan
[3] Mackay Mem Hospl, Dept Med Res, Taipei, Taiwan
关键词
D O I
10.1080/00365540510026869
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
The objective of this study was to investigate the role of sulbactam in the treatment of pan-drug resistant Acinetobacter baumannii (PDRAB). We studied 89 patients with PDRAB infection treated with different antibiotic regimens. Group A ( n = 59) were treated with carbapenem with sulbactam and group B ( n = 30) with second or third generation cephalosporins, antipseudomonas penicillins, or fluoroquinolones with aminoglycosides. We also studied the MICs for 48 PDRAB strains by using antimicrobial agents with and without sulbactam. The clinical outcomes of the 2 groups did not differ significantly, either in terms of resolution of infection (25/59, 42% in group A vs 12/30, 40% in group B) or survival (35/59, 59% vs 17/30, 57%). However, the MICs indicated that 16 of 48 strains were sensitive to imipenem/sulbactam, compared with only 2 of 48 to imipenem alone. The addition of sulbactam thus reversed the response in 30% (14/46) of strains initially resistant or only intermediate sensitive to imipenem. The MICs for meropenem/sulbactam were in the sensitive range for 8 of 48 strains compared to only 3 for meropenem alone, indicating an 11% (5/45) reversal rate when sulbactam was added to meropenem. For the 38 isolates initially resistant to both carbapenems alone, imipenem/sulbactam reversed the resistance in 16% (6/38), while meropenem/sulbactam did so in only 3% (1/38). Thus, the carbapenem-sulbactam combinations did not clearly improve clinical outcome, but they did demonstrate lower MICs for the PDRAB strains tested. It may be that aggressive, early treatment of A. baumanni infections with these agents might prevent the emergence of PDRAB strains.
引用
收藏
页码:195 / 199
页数:5
相关论文
共 24 条
  • [1] In vitro activities of nontraditional antimicrobials against multiresistant Acinetobacter baumannii strains isolated in an intensive care unit outbreak
    Appleman, MD
    Belzberg, H
    Citron, DM
    Heseltine, PNR
    Yellin, AE
    Murray, J
    Berne, TV
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (04) : 1035 - 1040
  • [2] In-vitro activity of cephalosporins alone and combined with sulbactam against various strains of Acinetobacter baumannii with different antibiotic resistance profiles
    Aubert, G
    Guichard, D
    Vedel, G
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1996, 37 (01) : 155 - 160
  • [3] BATAIBAR J, 1997, CHEST, V112, P1050
  • [4] CHOW AW, 1998, DIAGN MICROBIOL INFE, V9, P213
  • [5] Efficacy of sulbactam alone and in combination with ampicillin in nosocomial infections caused by multiresistant Acinetobacter baumannii
    Corbella, X
    Ariza, J
    Ardanuy, C
    Vuelta, M
    Tubau, F
    Sora, M
    Pujol, M
    Gudiol, F
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1998, 42 (06) : 793 - 802
  • [6] Emergence and rapid spread of carbapenem resistance during a large and sustained hospital outbreak of multiresistant Acinetobacter baumannii
    Corbella, X
    Montero, A
    Pujol, M
    Domínguez, MA
    Ayats, J
    Argerich, MJ
    Garrigosa, F
    Ariza, J
    Gudiol, F
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2000, 38 (11) : 4086 - 4095
  • [7] Carbapenem-resistant Acinetobacter and role of curtains in an outbreak in intensive care units
    Das, I
    Lambert, P
    Hill, D
    Noy, M
    Bion, J
    Elliott, T
    [J]. JOURNAL OF HOSPITAL INFECTION, 2002, 50 (02) : 110 - 114
  • [8] Mortality and the increase in length of stay attributable to the acquisition of Acinetobacter in critically ill patients
    García-Garmendia, JL
    Ortiz-Leyba, C
    Garnacho-Montero, J
    Jiménez-Jiménez, FJ
    Monterrubio-Villar, J
    Gili-Miner, M
    [J]. CRITICAL CARE MEDICINE, 1999, 27 (09) : 1794 - 1799
  • [9] CLINICAL AND MOLECULAR EPIDEMIOLOGY OF ACINETOBACTER INFECTIONS SENSITIVE ONLY TO POLYMYXIN-B AND SULBACTAM
    GO, ES
    URBAN, C
    BURNS, J
    KREISWIRTH, B
    EISNER, W
    MARIANO, N
    MOSINKASNIPAS, K
    RAHAL, JJ
    [J]. LANCET, 1994, 344 (8933) : 1329 - 1332
  • [10] Hsueh PR, 2002, EMERG INFECT DIS, V8, P827